Europe Learns The Truth(s) About ACTA
The truth about the Anti-Counterfeiting Trade Agreement (ACTA) is different depending on which side you are on.
Intellectual Property Watch
Original news and analysis on international IP policy
Year 2010
United States Sees Spate Of Intellectual Property Policy Activity
In the aftermath of the recent protracted fights over healthcare, the United States has seen a wave of intellectual property-related policy activity
Special Report: The Significance Of Europe’s Ruling On Google Ads And Trademarks
The European Court of Justice’s recent ruling in Google v. Louis Vuitton Malletier SA has been hailed a major legal victory for Google and other search providers. That, however, is only part of the story.
Brazil, US Reinvigorate Talks On Trade Retaliation
Brazil’s imposition of trade countermeasures against United States products and intellectual property rights, following a World Trade Organization (WTO) ruling, might be averted as the two countries are working toward a negotiated settlement.
UN Claims Victory In Biodiversity Talks, But Outcome Not Certain
The UN Convention on Biological Diversity last month hailed Cali, Colombia as the birthplace of a protocol they hope will lead to an international regime on access and benefit-sharing by their October 2010 deadline. But, while it is clear the late March negotiation in Cali brought significant progress, participants reported difficult disagreements and in the final days, signs that there is yet more work to be done.
ITU In A Converging World — Interview With ITU Strategist Alexander Ntoko
The International Telecommunication Union, based in Geneva, is a 191-member United Nations body. Intellectual Property Watch recently spoke with Alexander Ntoko, a top strategist in the organisation about priorities in this critical year, inclusion of the public interest, and how convergence is bringing more issues related to digital content to the traditional telecom body.
Risk Of Wrongful Medicines Seizures Seen In EU-Central America Trade Deal
A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
在WHO就假冒伪劣药品问题吹风会上观点激烈交锋
世界卫生组织就处理假冒伪劣（conterfeit）药品问题继续开展工作，但是上周晚些时候召开的一个会议暴露出一些方面对该组织的工作方式表示担心。
Débat houleux lors d’une réunion d’information organisée par l’OMS sur les médicaments contrefaits
Alors que l’Organisation mondiale de la Santé (OMS) continue de travailler sur la question des médicaments contrefaits, une réunion organisée en fin de semaine dernière a révélé des inquiétudes quant à la manière dont ce travail est mené.
China’s Latest Draft Disposal Rules For Patents In Standards A Step Forward?
On 21 January, 2010, the China National Institute of Standardization (CNIS) issued and requested comments from all stakeholders on its Disposal Rules for Inclusion of Patents in National Standards (Disposal Rules).
Unbiased HIV Patent Pool — A Free-Market, Middle-Income Countries Open Model
Brand name pharmaceutical companies’ concerns about profit losses related to the UNITAID patent pool might undermine access to newer and appropriate HIV medicine formulations in resource-limited settings. A universally agreed strategy to supplement UNITAID plan is therefore needed, writes Daniele Dionisio.
Mordaz intercambio de puntos de vista en la reunión informativa de la OMS sobre medicamentos falsificados
La Organización Mundial de la Salud (OMS) continúa trabajando en el tema de los medicamentos falsificados, pero la semana pasada una reunión reveló preocupaciones progresivas sobre la forma de conducir la labor.